Status:
COMPLETED
Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial
Lead Sponsor:
Planned Parenthood of Greater New York
Conditions:
Abortion, Induced
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study is a blinded randomized trial to compare two different doses and intervals of buccal misoprostol for cervical preparation before surgical abortion at 13 to 16 weeks' gestation: 400 mcg admi...
Detailed Description
The investigators compared two doses and intervals of buccal misoprostol for cervical preparation before surgical abortion at 13 to 16 weeks' gestation. This blinded randomized trial compared 400 mcg ...
Eligibility Criteria
Inclusion
- 18 years of age and older
- Eligible for pregnancy termination at Planned Parenthood of NYC
- Able to give informed consent
- English speaking
Exclusion
- Reports active bleeding, severe pain, or symptoms of spontaneous labor at enrollment
- Intrauterine fetal demise identified on pre-operative ultrasound
- Allergy to misoprostol
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT02279914
Start Date
November 1 2014
End Date
August 1 2016
Last Update
April 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Planned Parenthood of New York City - Margaret Sanger Center
New York, New York, United States, 10012